Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Efficacy and mechanism of action of FR-167653 in protecting against lung I/R injury

April 5, 2000

German researchers provide data supporting therapy with S-4718 + ciclosporin in cardiac transplants

April 5, 2000

Clinical study suggests SuperGen's Nipent effective in treating GVHD

April 5, 2000

AHP announces first launch of Prevnar

April 4, 2000

Anti-CD11a enters phase I/II study in kidney transplant patients

April 4, 2000

Phase III study of ETEC vaccine does not meet primary clinical endpoint

April 3, 2000

Immunostimulatory sequence designed by Dynavax reduces HSV-2 severity

March 30, 2000

Development and use of gene-based multivalent malaria vaccine

March 28, 2000

Glaxo Wellcome expands DNA vaccine program with PowderJect

March 28, 2000

Siga acquires Chlamydia vaccine technology from Oregon State University

March 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Coreterra Therapeutics patents agents for schizophrenia
BioWorld Science
Work at Coreterra Therapeutics Inc. has led to the discovery of new thienyl compounds intended for potential use in the treatment of schizophrenia.